abstract |
(57) Abstract: The present invention relates to angiotensinogen, angiotensin I (AI), an AI analog, an AI fragment and an analog thereof, an angiotensin II (AII), an AII analog, an AII fragment or an analog thereof, or It provides methods and kits to increase blood flow to ischemic tissues, which comprises administering an effective amount of AIIAT 2 2 receptor type agonist. |